Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.2K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

266
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
266
Pneumonia IV: Management01:28

Pneumonia IV: Management

359
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

268
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
268
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

336
The pathophysiology of pneumonia involves the following steps:
336
Vaccinations01:51

Vaccinations

44.7K
Overview
44.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Comparison of Type 2 Diabetes Mellitus Management by an Ambulatory Care Pharmacist vs Usual Care in a Medically Underserved Population.

Journal of pharmacy practice·2026
Same author

Impact of a charitable medication program and social vulnerability index on clinical outcomes in uninsured adults with diabetes.

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Improving Pancreatic Function With Elexacaftor/Tezacaftor/Ivacaftor.

Pediatric pulmonology·2026
Same author

One Size May Not Fit All: A Case Series.

Pediatric pulmonology·2026
Same author

Inclusion matters: Describing CF health inequities in American Indian/Alaska Native individuals in Oklahoma.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2026
Same author

Vitamin D and Marine n-3 Fatty Acids for Autoimmune Disease Prevention: Outcomes Two Years After Completion of a Double-Blind, Placebo-Controlled Trial.

Arthritis & rheumatology (Hoboken, N.J.)·2024

相关实验视频

Updated: Jul 18, 2025

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.7K

成年人的肺炎球菌疫苗接种

Joseph Walter1, Nicole Rudawsky

  • 1Joseph Walter is a clinical assistant professor at the Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey in Piscataway, and an ambulatory care pharmacist at JFK Family Medicine Center in Edison, NJ. Nicole Rudawsky is a medical science liaison at AstraZeneca. At the time of this writing, she was a clinical assistant professor at the Ernest Mario School of Pharmacy at Rutgers, and an internal medicine clinical pharmacy specialist at Morristown Medical Center. Contact author: Joseph Walter, joseph.walter@pharmacy.rutgers.edu . The authors have disclosed no potential conflicts of interest, financial or otherwise.

The American journal of nursing
|August 24, 2023
PubMed
概括

美国疾病控制和预防中心更新了成人肺炎球菌疫苗指南,引入PCV15和PCV20. 本综述涵盖了这些新型肺炎球菌结合疫苗的建议,益处,缺点和护理考虑.

更多相关视频

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.5K

相关实验视频

Last Updated: Jul 18, 2025

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

15.7K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.5K

科学领域:

  • 公共卫生 公共卫生
  • 免疫学 免疫学 免疫学
  • 疫苗学 疫苗学 疫苗学

背景情况:

  • 疾病控制和预防中心免疫实践咨询委员会 (ACIP) 制定了疫苗接种指南.
  • 肺炎球菌病仍然是一个重要的公共卫生问题,特别是在成年人中.
  • 现有的肺炎球菌疫苗存在局限性,需要更新建议.

研究的目的:

  • 审查ACIP针对成人肺炎球菌疫苗接种的最新建议.
  • 分析新推的肺炎球菌联合疫苗 (PCV),特别是PCV15和PCV20的优缺点.
  • 讨论这些更新的护理实践指南对护理实践的影响.

主要方法:

  • 对ACIP最新发布的肺炎球菌疫苗接种指南的审查.
  • 基于可用的临床数据和疗效研究,对PCV15和PCV20进行比较分析.
  • 综合有关疫苗安全性,免疫性和不同肺炎球菌血清型的覆盖范围的信息.

主要成果:

  • 现在更新的建议包括PCV15和PCV20用于成年人免疫.
  • 与以前的疫苗相比,PCV15和PCV20提供了更广泛的血清型覆盖范围.
  • 强调了疫苗测序和患者特定因素的考虑因素.

结论:

  • 引入PCV15和PCV20代表了预防成人肺炎球菌疾病的重大进展.
  • 护士在实施最新的疫苗接种策略和教育患者方面发挥着至关重要的作用.
  • 遵守最新的指导方针对于最大限度地提高疫苗的有效性和减少疾病负担至关重要.